NDC 15631-0083

BLATTA ORIENTALIS

Blatta Orientalis

BLATTA ORIENTALIS is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Blatta Orientalis.

Product ID15631-0083_86018e58-6600-4690-a613-b8ad438ecc64
NDC15631-0083
Product TypeHuman Otc Drug
Proprietary NameBLATTA ORIENTALIS
Generic NameBlatta Orientalis
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-09-12
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameBLATTA ORIENTALIS
Active Ingredient Strength2 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0083-0

100 PELLET in 1 PACKAGE (15631-0083-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0083-3 [15631008303]

BLATTA ORIENTALIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0083-0 [15631008300]

BLATTA ORIENTALIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0083-1 [15631008301]

BLATTA ORIENTALIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0083-5 [15631008305]

BLATTA ORIENTALIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0083-4 [15631008304]

BLATTA ORIENTALIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0083-2 [15631008302]

BLATTA ORIENTALIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

Drug Details

Active Ingredients

IngredientStrength
BLATTA ORIENTALIS2 [hp_X]/1

OpenFDA Data

SPL SET ID:af661231-79c6-4edc-8686-af6745ba06eb
Manufacturer
UNII

NDC Crossover Matching brand name "BLATTA ORIENTALIS" or generic name "Blatta Orientalis"

NDCBrand NameGeneric Name
0220-0868Blatta orientalisBLATTA ORIENTALIS
0220-0869Blatta orientalisBLATTA ORIENTALIS
0220-0871Blatta orientalisBLATTA ORIENTALIS
0220-0872Blatta orientalisBLATTA ORIENTALIS
0220-0873Blatta orientalisBLATTA ORIENTALIS
15631-0083BLATTA ORIENTALISBLATTA ORIENTALIS
15631-0540BLATTA ORIENTALISBLATTA ORIENTALIS
63545-499Blatta OrientalisBlatta Orientalis
63545-500Blatta OrientalisBlatta Orientalis
63545-501Blatta OrientalisBlatta Orientalis
63545-502Blatta OrientalisBlatta Orientalis
63545-503Blatta OrientalisBlatta Orientalis
63545-504Blatta OrientalisBlatta Orientalis
63545-505Blatta OrientalisBlatta Orientalis
68428-259Blatta orientalisBLATTA ORIENTALIS
71919-125Blatta orientalisBLATTA ORIENTALIS
69152-1020Blatta orientalis 30CBlatta orientalis
64117-117CoughBLATTA ORIENTALIS

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.